FDA Inspection
Strides Pharma Science LimitedStrides Pharma Science Limited – FDA Inspection, Jan 17, 2020
Record Details
This FDA Inspection record concerns Strides Pharma Science Limited, with an inspection on January 17, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 17, 2020
- Product Type
- Drugs
View Company Profile
ID · be553f53-b876-4b0e-b659-2d85ce070721
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115442
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Extent of discrepancy, failure investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Strides Pharma Science Limited
10| Date | Classification | Office | Project area |
|---|---|---|---|
| December 9, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 5, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 2, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Strides Pharma Science Limited
- FDA Inspection 1195160 - 2022-12-09
- FDA Inspection 1119886 - 2020-03-05
- FDA Inspection 1091356 - 2019-05-24
- FDA Inspection 1074883 - 2018-11-02
- FDA Inspection 1065956 - 2018-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.